Skip to main content

CZI teams up with UCSF and Stanford to research COVID-19’s prevalence in the Bay Area

With $13.6 million in funding from the Chan Zuckerberg Initiative, a new  collaboration will pull together researchers at UCSF, Stanford and CZI-adjacent medical research nonprofit the Chan Zuckerberg Biohub to study the spread of COVID-19 in the Bay Area. The research team will conduct two separate large-scale studies over the course of nine months as part of the data-intensive public health effort, which seeks to answer some key questions about the virus that have eluded researchers.

For the first study, researchers will recruit 4,500 Bay Area residents who previously came up negative for the virus, testing them one time each month with both a serological test that detects antibodies and a polymerase chain reaction (PCR) test, which detects the presence of infection. Using viral genome data, the research teams hope to glean insight on the chain of transmission within the area as well as any evidence about how that the virus traveled into the community from outside the region.

The second study will examine COVID-19 infection among Bay Area healthcare workers, and the potential that an infection results in immunity from the virus—an area of current “significant knowledge gaps.” That research will follow 3,500 healthcare workers in the Bay Area who are negative for the virus, tracking them for three months of testing to determine infection trends among frontline health workers.

Both studies aim to collect data that can be translated directly into local public health policy.

“To reopen society in the Bay Area and keep healthcare workers safe, we need to first understand the epidemiology of this disease,” CZI co-founder Dr. Priscilla Chan said of the research.



from TechCrunch https://ift.tt/2yVPtkp
via IFTTT

Comments

Popular posts from this blog

Max Q: Psyche(d)

In this issue: SpaceX launches NASA asteroid mission, news from Relativity Space and more. © 2023 TechCrunch. All rights reserved. For personal use only. from TechCrunch https://ift.tt/h6Kjrde via IFTTT

Max Q: Anomalous

Hello and welcome back to Max Q! Last week wasn’t the most successful for spaceflight missions. We’ll get into that a bit more below. In this issue: First up, a botched launch from Virgin Orbit… …followed by one from ABL Space Systems News from Rocket Lab, World View and more Virgin Orbit’s botched launch highlights shaky financial future After Virgin Orbit’s launch failure last Monday, during which the mission experienced an  “anomaly” that prevented the rocket from reaching orbit, I went back over the company’s financials — and things aren’t looking good. For Virgin Orbit, this year has likely been completely turned on its head. The company was aiming for three launches this year, but everything will remain grounded until the cause of the anomaly has been identified and resolved. It’s unclear how long that will take, but likely at least three months. Add this delay to Virgin’s dwindling cash reserves and you have a foundation that’s suddenly much shakier than before. ...

What’s Stripe’s deal?

Welcome to  The Interchange ! If you received this in your inbox, thank you for signing up and your vote of confidence. If you’re reading this as a post on our site, sign up  here  so you can receive it directly in the future. Every week, I’ll take a look at the hottest fintech news of the previous week. This will include everything from funding rounds to trends to an analysis of a particular space to hot takes on a particular company or phenomenon. There’s a lot of fintech news out there and it’s my job to stay on top of it — and make sense of it — so you can stay in the know. —  Mary Ann Stripe eyes exit, reportedly tried raising at a lower valuation The big news in fintech this week revolved around payments giant Stripe . On January 26, my Equity Podcast co-host and overall amazingly talented reporter Natasha Mascarenhas and I teamed up to write about how Stripe had set a 12-month deadline for itself to go public, either through a direct listing or by pursuin...